AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.
Agility Robotic's legged locomotion expertise is built on a history of academic research, including the bipedal walking and running robot ATRIAS. Agility Robotics is leveraging this work to create products that address the real world needs of rugged, efficient, and highly capable mobility platforms.
Alation pioneered the data catalog market and today is leading its evolution into a platform for a broad range of data intelligence solutions including data search & discovery, data governance, data stewardship, analytics, and digital transformation. Thanks to its powerful Behavioral Analysis Engine, inbuilt collaboration capabilities, and open interfaces, Alation combines machine learning with human insight to successfully tackle even the most demanding challenges in data and metadata management. More than 240 enterprises drive data culture, improve decision making, and realize business outcomes with Alation including AbbVie, American Family Insurance, Cisco, Exelon, Finnair, Munich Re, New Balance, Pfizer, Scandinavian Airlines, and US Foods. Headquartered in Silicon Valley, Alation is backed by leading venture capitalists including Costanoa, Data Collective, Icon, Sapphire, and Salesforce Ventures.
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases.
Aquafortus Technologies Limited is a company at the cutting edge of water technology. Aquafortus has developed a novel non-thermal liquid to liquid crystallizer (the ABXTM), that reduces wastewater brine to dry salt and clean water. Zero Liquid Discharge (ZLD) means that practically all the water is recovered from the wastewater and that the remaining waste can be shovelled onto a truck for final disposal. The ZLD market has grown rapidly due to government regulations globally that compelled heavily polluting and water-intensive industries to go ZLD or face massive fines and ultimately be shut down. Aquafortus’ ABXTM system is a novel liquid-to-liquid crystallizer that promotes the formation of salt crystals via a proprietary direct contact crystallization process using Aquafortus’ patented solutions, which are called the Aquafortus Absorbent and the Aquafortus Regenerant. The ABXTM system efficiently reduces highly concentrated brines to dry salt and produces clean water. The Aquafortus Absorbent can precipitate all salts commonly found in industrial wastewaters, including troublesome salts like lithium chloride. The Aquafortus ABXTM system is the only known continuous and regenerable process that can wholly replace energy intensive Thermal Crystallizers in a ZLD treatment train.
Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.
Axelar is a cross-chain communication tool developing interoperability software to connect blockchain ecosystems, applications, and users. Axelar Network consists of a protocol suite, tools, and APIs, designed to break down the barriers to cross-chain communication. Axelar enables developers to build on the best platform for their needs while leveraging the Axelar stack to unlock cross-chain composability and liquidity.
Brimstone is on a mission to decarbonize the cement industry. The $1 trillion cement market is responsible for 7.5% of carbon emissions annually, with a greenhouse gas impact just behind cars. Founded in 2019, Brimstone developed a breakthrough carbon-negative process to produce the same ordinary portland cement and supplementary cementitious materials used today. These materials have the same quality and performance builders have trusted for over 150 years — now with a positive climate impact.
Capella Space is an information services company that provides sub 0.5m very high-resolution synthetic aperture radar earth observation imagery. Through a constellation of small satellites, Capella is providing easy access to frequent, timely, and flexible information affecting dozens of industries worldwide. Capella’s high-resolution SAR satellites are matched with unparalleled infrastructure to deliver reliable global insights that sharpen the understanding of the changing world, improving decisions about commerce, conservation, and well-being on Earth. The company aims to make timely Earth observation an essential tool for commerce, conservation, and well-being. Capella Space was founded in 2014 and based in San Francisco, California.
Caption Health will use this funding to scale up its commercial operations, continue to develop its AI technology platform and form new partnerships. As more providers adopt the Caption AI platform, the company plans to add new clinical capabilities to expand the use of Caption AI in additional care settings.
Carbon Health is a tech-enabled healthcare company that delivers virtual care experience. It offers primary care services through a mobile application that enables users to follow-up on a treatment plan, manage prescriptions, and see lab reports all through one app. Carbon Health has created a coronavirus assessment tool and also set up covid-19 testing in California. The company was founded in 2015 and is headquartered in San Francisco, California.
CH4 Global is an aquaculture solutions provider dedicated to urgently impacting climate change. Lead by a world-class team of senior business builders, scientists and entrepreneurs, the company is initially leveraging proven science and technology for growing seaweed into innovative new livestock supplement that reduces methane produced by cows by up to 90%. Among early investors are a select group of prominent family offices and private investors. CH4 Global have also received non-dilutive capital support from government organizations from around the world. CH4 Global is a Delaware corporation based in San Francisco, CA.